{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:17Z","timestamp":1707524657802},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,23]]},"DOI":"10.7759\/cureus.30622","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T06:44:40Z","timestamp":1666593880000},"source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Review of Pulmonary Hypertension and Treatment Options in the Paediatric Population"],"prefix":"10.7759","author":[{"given":"Pragyna D","family":"Parmita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana R","family":"Thool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56120716","article-title":"COVID-19 and pulmonary hypertension in children: what do we know so far?","volume":"56","author":"Das BB","year":"2020","unstructured":"Das BB. COVID-19 and pulmonary hypertension in children: what do we know so far?. Medicina (Kaunas). 2020, 56:716. 10.3390\/medicina56120716","journal-title":"Medicina (Kaunas)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2021.110483","article-title":"COVID-19 patients may become predisposed to pulmonary arterial hypertension","volume":"147","author":"Suzuki YJ","year":"2021","unstructured":"Suzuki YJ, Nikolaienko SI, Shults NV, Gychka SG. COVID-19 patients may become predisposed to pulmonary arterial hypertension. Med Hypotheses. 2021, 147:110483. 10.1016\/j.mehy.2021.110483","journal-title":"Med Hypotheses"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.12.005","article-title":"Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: state of the art review","volume":"40","author":"Wesley Milks M","year":"2021","unstructured":"Wesley Milks M, Sahay S, Benza RL, Farber HW. Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: state of the art review. J Heart Lung Transplant. 2021, 40:172-82. 10.1016\/j.healun.2020.12.005","journal-title":"J Heart Lung Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: deleterious impact on infected patients","volume":"13","author":"Ejaz H","year":"2020","unstructured":"Ejaz H, Alsrhani A, Zafar A, et al.. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020, 13:1833-9. 10.1016\/j.jiph.2020.07.014","journal-title":"J Infect Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang L","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. 2020, 8:e21. 10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01217-2020","article-title":"Abnormal pulmonary function in COVID-19 patients at time of hospital discharge","volume":"55","author":"Mo X","year":"2020","unstructured":"Mo X, Jian W, Su Z, et al.. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020, 55:2001217. 10.1183\/13993003.01217-2020","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0073","article-title":"Pulmonary hypertension","volume":"114","author":"Hoeper MM","year":"2017","unstructured":"Hoeper MM, Ghofrani HA, Gr\u00fcnig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary hypertension. Dtsch Arztebl Int. 2017, 114:73-84. 10.3238\/arztebl.2017.0073","journal-title":"Dtsch Arztebl Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00004910","article-title":"Optimising the management of pulmonary arterial hypertension patients: emergency treatments","volume":"19","author":"Delcroix M","year":"2010","unstructured":"Delcroix M, Naeije R. Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev. 2010, 19:204-11. 10.1183\/09059180.00004910","journal-title":"Eur Respir Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li W","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, et al.. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003, 426:450-4. 10.1038\/nature02145","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa N","year":"2019","unstructured":"Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. 2019, 93:10.1128\/JVI.01815-18","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa053","article-title":"The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system","volume":"6","author":"Offringa A","year":"2020","unstructured":"Offringa A, Montijn R, Singh S, Paul M, Pinto YM, Pinto-Sietsma SJ. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system. Eur Heart J Cardiovasc Pharmacother. 2020, 6:317-25. 10.1093\/ehjcvp\/pvaa053","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.04.039","article-title":"Pulmonary hypertension: a brief guide for clinicians","volume":"95","author":"Mandras SA","year":"2020","unstructured":"Mandras SA, Mehta HS, Vaidya A. Pulmonary hypertension: a brief guide for clinicians. Mayo Clin Proc. 2020, 95:1978-88. 10.1016\/j.mayocp.2020.04.039","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Gali\u00e8 N","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al.. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015, 46:903-75. 10.1183\/13993003.01032-2015","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst RJ","year":"2012","unstructured":"Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012, 125:113-22. 10.1161\/CIRCULATIONAHA.111.026591","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00140112","article-title":"Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice","volume":"42","author":"Beghetti M","year":"2013","unstructured":"Beghetti M, Berger RM, Schulze-Neick I, et al.. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur Respir J. 2013, 42:689-700. 10.1183\/09031936.00140112","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.03.575","article-title":"Pulmonary hypertension in infants, children, and young adults","volume":"69","author":"Hansmann G","year":"2017","unstructured":"Hansmann G. Pulmonary hypertension in infants, children, and young adults. J Am Coll Cardiol. 2017, 69:2551-69. 10.1016\/j.jacc.2017.03.575","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.016","article-title":"Interventional and surgical modalities of treatment in pulmonary hypertension","volume":"54","author":"Keogh AM","year":"2009","unstructured":"Keogh AM, Mayer E, Benza RL, et al.. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009, 54:S67-77. 10.1016\/j.jacc.2009.04.016","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00089610","article-title":"A noninvasive algorithm to exclude pre-capillary pulmonary hypertension","volume":"37","author":"Bonderman D","year":"2011","unstructured":"Bonderman D, Wexberg P, Martischnig AM, et al.. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011, 37:1096-103. 10.1183\/09031936.00089610","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.2.513","article-title":"The prognostic role of the ECG in primary pulmonary hypertension","volume":"121","author":"Bossone E","year":"2002","unstructured":"Bossone E, Paciocco G, Iarussi D, Agretto A, Iacono A, Gillespie BW, Rubenfire M. The prognostic role of the ECG in primary pulmonary hypertension. Chest. 2002, 121:513-8. 10.1378\/chest.121.2.513","journal-title":"Chest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson KM","year":"2013","unstructured":"Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013, 167:2300-5. 10.1016\/j.ijcard.2012.06.024","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich S","year":"1987","unstructured":"Rich S, Dantzker DR, Ayres SM, et al.. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987, 107:216-23. 10.7326\/0003-4819-107-2-216","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1148\/rg.324125021","article-title":"Forgotten gold in diagnosing pulmonary hypertension: the plain chest radiograph","volume":"32","author":"Milne EN","year":"2012","unstructured":"Milne EN. Forgotten gold in diagnosing pulmonary hypertension: the plain chest radiograph. Radiographics. 2012, 32:1085-7. 10.1148\/rg.324125021","journal-title":"Radiographics"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip P","year":"2013","unstructured":"Trip P, Nossent EJ, de Man FS, et al.. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013, 42:1575-85. 10.1183\/09031936.00184412","journal-title":"Eur Respir J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)02964-9","article-title":"Pulmonary function in primary pulmonary hypertension","volume":"41","author":"Sun XG","year":"2003","unstructured":"Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003, 41:1028-35. 10.1016\/s0735-1097(02)02964-9","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028351","article-title":"Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension","volume":"136","author":"Hadinnapola C","year":"2017","unstructured":"Hadinnapola C, Bleda M, Haimel M, et al.. Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation. 2017, 136:2022-33. 10.1161\/CIRCULATIONAHA.117.028351","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski LG","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, et al.. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010, 23:685-713. 10.1016\/j.echo.2010.05.010","journal-title":"J Am Soc Echocardiogr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1086\/683815","article-title":"Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice","volume":"5","author":"Berry NC","year":"2015","unstructured":"Berry NC, Manyoo A, Oldham WM, et al.. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015, 5:610-8. 10.1086\/683815","journal-title":"Pulm Circ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.093198","article-title":"Exercise pathophysiology in patients with primary pulmonary hypertension","volume":"104","author":"Sun XG","year":"2001","unstructured":"Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001, 104:429-35. 10.1161\/hc2901.093198","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2013.01.013","article-title":"Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry","volume":"6","author":"Swift AJ","year":"2013","unstructured":"Swift AJ, Rajaram S, Hurdman J, et al.. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging. 2013, 6:1036-47. 10.1016\/j.jcmg.2013.01.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00006313","article-title":"Cardiac magnetic resonance imaging in pulmonary arterial hypertension","volume":"22","author":"Peacock AJ","year":"2013","unstructured":"Peacock AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev. 2013, 22:526-34. 10.1183\/09059180.00006313","journal-title":"Eur Respir Rev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06373-9","article-title":"Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent","volume":"353","author":"Albrecht T","year":"1999","unstructured":"Albrecht T, Blomley MJ, Cosgrove DO, et al.. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999, 353:1579-83. 10.1016\/S0140-6736(98)06373-9","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens C","year":"2001","unstructured":"Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest. 2001, 120:1562-9. 10.1378\/chest.120.5.1562","journal-title":"Chest"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick G","year":"2008","unstructured":"Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J. 2008, 32:503-12. 10.1183\/09031936.00160307","journal-title":"Eur Respir J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-309132","article-title":"Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK","volume":"102","author":"Hansmann G","year":"2016","unstructured":"Hansmann G, Apitz C, Abdul-Khaliq H, et al.. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016, 102:ii86-100. 10.1136\/heartjnl-2015-309132","journal-title":"Heart"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Gali\u00e9 N","year":"2004","unstructured":"Gali\u00e9 N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004, 61:227-37. 10.1016\/j.cardiores.2003.11.026","journal-title":"Cardiovasc Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00030414","article-title":"Identification of treatment goals in paediatric pulmonary arterial hypertension","volume":"44","author":"Ploegstra MJ","year":"2014","unstructured":"Ploegstra MJ, Douwes JM, Roofthooft MT, Zijlstra WM, Hillege HL, Berger RM. Identification of treatment goals in paediatric pulmonary arterial hypertension. Eur Respir J. 2014, 44:1616-26. 10.1183\/09031936.00030414","journal-title":"Eur Respir J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"Mayer E","year":"2011","unstructured":"Mayer E, Jenkins D, Lindner J, et al.. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011, 141:702-10. 10.1016\/j.jtcvs.2010.11.024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.06.012","article-title":"Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension","volume":"155","author":"Steinhorn RH","year":"2009","unstructured":"Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M, Wessel DL. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr. 2009, 155:841-7.e1. 10.1016\/j.jpeds.2009.06.012","journal-title":"J Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109038-comprehensive-review-of-pulmonary-hypertension-and-treatment-options-in-the-paediatric-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:48Z","timestamp":1707507828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109038-comprehensive-review-of-pulmonary-hypertension-and-treatment-options-in-the-paediatric-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,23]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.30622","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,23]]}}}